Download PDF
Horm Metab Res 2008; 40(2): 99-107
DOI: 10.1055/s-2007-1022561
Review

© Georg Thieme Verlag KG Stuttgart · New York

Dendritic Cell Subtypes and In Vitro Generation of Dendritic Cells

B. Jacobs 1 , M. Wuttke 1 , C. Papewalis 1 , J. Seissler 2 , M. Schott 1
  • 1Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany
  • 2Medical Clinic Innensadt, Ludwig-Maximilians-University Muenchen, Muenchen, Germany
Further Information

Publication History

received 15.10.2007

accepted 26.11.2007

Publication Date:
19 February 2008 (online)

Also available at
    Permissions and Reprints

Abstract

Dendritic cells (DCs) are highly potent antigen-presenting cells crucial for the innate and adaptive immune response and for maintaining immune tolerance towards self-antigens. Although they share many common features, multiple DC subtypes with different immune functions have been identified. Originally, DCs were considered to be cells with purely myeloid origin. Recent studies have now demonstrated that DCs can also develop from lymphatic progenitors. Various cytokines and transcription factors are known to be responsible for the development of DC subpopulation. Depending on the subpopulation and the maturation state of these cells, they are either able to induce a broad cytotoxic immune response, and therefore represent a promising tool for anticancer vaccination therapies in humans or induce immune tolerance and are important within the context of autoimmunity. This review will focus on recent advances on the identification of different DC subpopulations including phenotypical and functional differences and on recent developments on protocols for in vitro generation of myeloid-derived DCs.

Key words

dendritic cells - subtypes - in vitro generation - myeloid dendritic cells - plasmocytoid dendritic cells - immunity

References

  • 1 Steinman RM. The dendritic cell system and its role in immunogenicity.  Annu Rev Immunol. 1991;  9 271-296
    CrossrefPubMedGoogle Scholar
  • 2 Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ. et al . Immunobiology of dendritic cells.  Annu Rev Immunol. 2000;  18 767-811
    CrossrefPubMedGoogle Scholar
  • 3 Schott M. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.  Endocr Relat Cancer. 2006;  13 779-795
    CrossrefPubMedGoogle Scholar
  • 4 Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.  Immunity. 2003;  19 225-234
    CrossrefPubMedGoogle Scholar
  • 5 Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M. et al . Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.  Nat Med. 1999;  5 405-411
    PubMedGoogle Scholar
  • 6 Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA. et al . Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells.  J Exp Med. 2001;  193 1221-1226
    CrossrefPubMedGoogle Scholar
  • 7 Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L. et al . Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.  J Immunol. 2004;  172 5363-5370
    PubMedGoogle Scholar
  • 8 Munz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity.  J Exp Med. 2005;  202 203-207
    CrossrefPubMedGoogle Scholar
  • 9 Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.  J Exp Med. 2003;  198 267-279
    CrossrefPubMedGoogle Scholar
  • 10 Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.  J Exp Med. 1973;  137 1142-1162
    CrossrefPubMedGoogle Scholar
  • 11 Wu L, Liu YJ. Development of dendritic-cell lineages.  Immunity. 2007;  26 741-750
    CrossrefPubMedGoogle Scholar
  • 12 Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells.  J Exp Med. 1998;  187 961-966
    CrossrefPubMedGoogle Scholar
  • 13 Naik SH, Corcoran LM, Wu L. Development of murine plasmacytoid dendritic cell subsets.  Immunol Cell Biol. 2005;  83 563-570
    PubMedGoogle Scholar
  • 14 Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.  Immunity. 1999;  11 753-761
    CrossrefPubMedGoogle Scholar
  • 15 Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.  Immunity. 2003;  19 59-70
    CrossrefPubMedGoogle Scholar
  • 16 Inaba K, Inaba M, Deguchi M, Hagi K, Yasumizu R, Ikehara S. et al . Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.  Proc Natl Acad Sci USA. 1993;  90 3038-3042
    CrossrefPubMedGoogle Scholar
  • 17 Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.  J Immunol. 1992;  149 2681-2688
    PubMedGoogle Scholar
  • 18 Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA, Steinman RM. et al . Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.  Blood. 1996;  87 4520-4530
    PubMedGoogle Scholar
  • 19 Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, Saint-Vis B, Jacquet C. et al . CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.  J Exp Med. 1996;  184 695-706
    CrossrefPubMedGoogle Scholar
  • 20 Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B. et al . Proliferating dendritic cell progenitors in human blood.  J Exp Med. 1994;  180 83-93
    CrossrefPubMedGoogle Scholar
  • 21 Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.  J Exp Med. 1994;  179 1109-1118
    CrossrefPubMedGoogle Scholar
  • 22 Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M. et al . Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes.  Blood. 1996;  88 4029-4039
    PubMedGoogle Scholar
  • 23 Kiertscher SM, Roth MD. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.  J Leukoc Biol. 1996;  59 208-218
    PubMedGoogle Scholar
  • 24 Pickl WF, Majdic O, Kohl P, Stockl J, Riedl E, Scheinecker C. et al . Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.  J Immunol. 1996;  157 3850-3859
    PubMedGoogle Scholar
  • 25 Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.  Proc Natl Acad Sci USA. 1996;  93 ((6)) 2588-2592
    CrossrefPubMedGoogle Scholar
  • 26 Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro.  Eur J Immunol. 1997;  27 431-441
    CrossrefPubMedGoogle Scholar
  • 27 Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG. et al . Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.  Science. 2000;  290 ((5499)) 2152-2154
    CrossrefPubMedGoogle Scholar
  • 28 Wu L, D’Amico A, Hochrein H, O’keeffe M, Shortman K, Lucas K. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors.  Blood. 2001;  98 3376-3382
    CrossrefPubMedGoogle Scholar
  • 29 Manz MG, Traver D, Akashi K, Merad M, Miyamoto T, Engleman EG. et al . Dendritic cell development from common myeloid progenitors.  Ann N Y Acad Sci. 2001;  938 167-173
    PubMedGoogle Scholar
  • 30 D’Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3.  J Exp Med. 2003;  198 293-303
    CrossrefPubMedGoogle Scholar
  • 31 Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR. et al . A clonogenic bone marrow progenitor specific for macrophages and dendritic cells.  Science. 2006;  311 ((5757)) 83-87
    CrossrefPubMedGoogle Scholar
  • 32 Wu L, Vremec D, Ardavin C, Winkel K, Suss G, Georgiou H. et al . Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation.  Eur J Immunol. 1995;  25 418-425
    CrossrefPubMedGoogle Scholar
  • 33 Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population.  Nature. 1993;  362 ((6422)) 761-763
    CrossrefPubMedGoogle Scholar
  • 34 Wu L, Li CL, Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny.  J Exp Med. 1996;  184 903-911
    CrossrefPubMedGoogle Scholar
  • 35 Martin P, del Hoyo GM, Anjuere F, Ruiz SR, Arias CF, Marin AR. et al . Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors.  Blood. 2000;  96 2511-2519
    PubMedGoogle Scholar
  • 36 Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors.  Blood. 2001;  97 3333-3341
    CrossrefPubMedGoogle Scholar
  • 37 Izon D, Rudd K, DeMuth W, Pear WS, Clendenin C, Lindsley RC. et al . A common pathway for dendritic cell and early B cell development.  J Immunol. 2001;  167 1387-1392
    PubMedGoogle Scholar
  • 38 Dakic A, Wu L. Hemopoietic precursors and development of dendritic cell populations.  Leuk Lymphoma. 2003;  44 1469-1475
    CrossrefPubMedGoogle Scholar
  • 39 Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.  J Exp Med. 1997;  185 1101-1111
    CrossrefPubMedGoogle Scholar
  • 40 Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, Waal MR de. et al . Reciprocal control of T helper cell and dendritic cell differentiation.  Science. 1999;  283 ((5405)) 1183-1186
    CrossrefPubMedGoogle Scholar
  • 41 Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.  J Exp Med. 2000;  192 1775-1784
    CrossrefPubMedGoogle Scholar
  • 42 Schotte R, Nagasawa M, Weijer K, Spits H, Blom B. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development.  J Exp Med. 2004;  200 1503-1509
    CrossrefPubMedGoogle Scholar
  • 43 Chicha L, Jarrossay D, Manz MG. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations.  J Exp Med. 2004;  200 1519-1524
    CrossrefPubMedGoogle Scholar
  • 44 Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, Traver D. et al . Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin.  Immunity. 2004;  21 43-53
    CrossrefPubMedGoogle Scholar
  • 45 Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer.  Curr Opin Immunol. 2004;  16 151-156
    CrossrefPubMedGoogle Scholar
  • 46 Steinman RM, Mellman I. Immunotherapy: bewitched, bothered, and bewildered no more.  Science. 2004;  305 ((5681)) 197-200
    CrossrefPubMedGoogle Scholar
  • 47 Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.  Nat Immunol. 2000;  1 510-514
    CrossrefPubMedGoogle Scholar
  • 48 Peters JH, Xu H, Ruppert J, Ostermeier D, Friedrichs D, Gieseler RK. Signals required for differentiating dendritic cells from human monocytes in vitro.  Adv Exp Med Biol. 1993;  329 275-280
    PubMedGoogle Scholar
  • 49 Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J. et al . Type I IFNs enhance the terminal differentiation of dendritic cells.  J Immunol. 1998;  161 1947-1953
    PubMedGoogle Scholar
  • 50 Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T. et al . Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.  J Exp Med. 2000;  191 1777-1788
    CrossrefPubMedGoogle Scholar
  • 51 Banchereau J, Steinman RM. Dendritic cells and the control of immunity.  Nature. 1998;  392 ((6673)) 245-252
    CrossrefPubMedGoogle Scholar
  • 52 Siena S, Nicola M Di, Bregni M, Mortarini R, Anichini A, Lombardi L. et al . Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.  Exp Hematol. 1995;  23 1463-1471
    PubMedGoogle Scholar
  • 53 Chen CH, Wu TC. Experimental vaccine strategies for cancer immunotherapy.  J Biomed Sci. 1998;  5 231-252
    CrossrefPubMedGoogle Scholar
  • 54 Nowrousian MR, Waschke S, Bojko P, Welt A, Schuett P, Ebeling P. et al . Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients.  Ann Oncol. 2003;  14 ((Suppl 1)) i29-i36
    CrossrefPubMedGoogle Scholar
  • 55 Franzke A. The role of G-CSF in adaptive immunity.  Cytokine Growth Factor Rev. 2006;  17 235-244
    CrossrefPubMedGoogle Scholar
  • 56 Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.  J Immunol. 1995;  154 3821-3835
    PubMedGoogle Scholar
  • 57 Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B. et al . Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.  J Immunol Meth. 1996;  196 137-151
    CrossrefPubMedGoogle Scholar
  • 58 Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.  J Immunol Meth. 1996;  196 121-135
    CrossrefPubMedGoogle Scholar
  • 59 O’Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I. et al . Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.  J Exp Med. 1993;  178 1067-1076
    CrossrefPubMedGoogle Scholar
  • 60 Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E. et al . Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.  Eur J Immunol. 1997;  27 3135-3142
    CrossrefPubMedGoogle Scholar
  • 61 Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H. et al . Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.  J Exp Med. 1999;  190 1669-1678
    CrossrefPubMedGoogle Scholar
  • 62 Jonuleit H, Giesecke-Tuettenberg A, Tuting T, Thurner-Schuler B, Stuge TB, Paragnik L. et al . A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.  Int J Cancer. 2001;  93 243-251
    CrossrefPubMedGoogle Scholar
  • 63 Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines.  Nat Med. 2004;  10 909-915
    CrossrefPubMedGoogle Scholar
  • 64 Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Brocker EB. et al . Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.  Ann Oncol. 2006;  17 563-570
    CrossrefPubMedGoogle Scholar
  • 65 Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.  Blood. 2002;  100 1354-1361
    CrossrefPubMedGoogle Scholar
  • 66 Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA. et al . Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.  Blood. 2002;  100 1362-1372
    CrossrefPubMedGoogle Scholar
  • 67 Morelli AE, Thomson AW. Dendritic cells under the spell of prostaglandins.  Trends Immunol. 2003;  24 108-111
    CrossrefPubMedGoogle Scholar
  • 68 Banerjee DK, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar KM. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients.  Blood. 2006;  108 2655-2661
    CrossrefPubMedGoogle Scholar
  • 69 Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML. et al . Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.  Cancer Res. 2004;  64 5934-5937
    CrossrefPubMedGoogle Scholar
  • 70 Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function.  Nat Immunol. 2005;  6 163-170
    CrossrefPubMedGoogle Scholar
  • 71 Gutterman JU. Cytokine therapeutics: lessons from interferon alpha.  Proc Natl Acad Sci USA. 1994;  91 1198-1205
    CrossrefPubMedGoogle Scholar
  • 72 Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R. et al . Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.  Cancer Res. 1998;  58 2489-2499
    PubMedGoogle Scholar
  • 73 Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S. et al . The nature of the principal type 1 interferon-producing cells in human blood.  Science. 1999;  284 ((5421)) 1835-1837
    CrossrefPubMedGoogle Scholar
  • 74 Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA.  J Exp Med. 1998;  188 2335-2342
    CrossrefPubMedGoogle Scholar
  • 75 Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive.  J Exp Med. 1999;  189 521-530
    CrossrefPubMedGoogle Scholar
  • 76 Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.  J Exp Med. 2005;  202 637-650
    CrossrefPubMedGoogle Scholar
  • 77 Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.  J Exp Med. 1978;  147 1314-1333
    CrossrefPubMedGoogle Scholar
  • 78 Mohty M, Vialle-Castellano A, Nunes JA, Isnardon D, Olive D, Gaugler B. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.  J Immunol. 2003;  171 3385-3393
    PubMedGoogle Scholar
  • 79 Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, Roth MD. et al . Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells.  J Leukoc Biol. 1998;  64 358-367
    PubMedGoogle Scholar
  • 80 Della BS, Nicola S, Riva A, Biasin M, Clerici M, Villa ML. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.  J Leukoc Biol. 2004;  75 106-116
    PubMedGoogle Scholar
  • 81 Gabriele L, Borghi P, Rozera C, Sestili P, Andreotti M, Guarini A. et al . IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment.  Blood. 2004;  103 980-987
    PubMedGoogle Scholar
  • 82 Adema GJ, Hartgers F, Verstraten R, Vries E de, Marland G, Menon S. et al . A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells.  Nature. 1997;  387 ((6634)) 713-717
    CrossrefPubMedGoogle Scholar
  • 83 Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.  J Exp Med. 1998;  187 875-883
    CrossrefPubMedGoogle Scholar
  • 84 Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M. et al . The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.  J Clin Invest. 1998;  101 746-754
    CrossrefPubMedGoogle Scholar
  • 85 Parlato S, Santini SM, Lapenta C, Di Pucchio T, Logozzi M, Spada M. et al . Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities.  Blood. 2001;  98 3022-3029
    CrossrefPubMedGoogle Scholar
  • 86 Breckpot K, Corthals J, Bonehill A, Michiels A, Tuyaerts S, Aerts C. et al . Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response.  J Leukoc Biol. 2005;  78 898-908
    CrossrefPubMedGoogle Scholar
  • 87 Papewalis C, Jacobs B, Wuttke B, Ullrich E, Fenk R, Willenberg H. et al . IFN-alpha Skews Monocyte into CD56+ expressing Dendritic Cells with Potent Functional Activities in vitro and in vivo.  J Immunol. 2008;  , in press
    PubMedGoogle Scholar
  • 88 Banchereau J, Ueno H, Dhodapkar M, Connolly J, Finholt JP, Klechevsky E. et al . Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.  J Immunother (1997). 2005;  28 505-516
    CrossrefPubMedGoogle Scholar
  • 89 Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P. et al . Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.  J Exp Med. 2002;  195 1279-1288
    CrossrefPubMedGoogle Scholar
  • 90 Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK. TNF skews monocyte differentiation from macrophages to dendritic cells.  J Immunol. 2003;  171 2262-2269
    PubMedGoogle Scholar
  • 91 Luft T, Pang KC, Thomas E, Bradley CJ, Savoia H, Trapani J. et al . A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells.  Exp Hematol. 1998;  26 489-500
    PubMedGoogle Scholar
  • 92 Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M. et al . TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.  J Immunol. 2007;  179 1449-1457
    PubMedGoogle Scholar
  • 93 Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells.  Nat Immunol. 2000;  1 311-316
    CrossrefPubMedGoogle Scholar
  • 94 Mohamadzadeh M, Berard F, Essert G, Chalouni C, Pulendran B, Davoust J. et al . Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells.  J Exp Med. 2001;  194 1013-1020
    CrossrefPubMedGoogle Scholar
  • 95 Dubsky P, Saito H, Leogier M, Dantin C, Connolly JE, Banchereau J. et al . IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.  Eur J Immunol. 2007;  37 1678-1690
    CrossrefPubMedGoogle Scholar
  • 96 Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B. et al . Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.  Nat Immunol. 2002;  3 673-680
    PubMedGoogle Scholar
  • 97 Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M. et al . Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.  J Immunol. 2001;  167 336-343
    PubMedGoogle Scholar
  • 98 O’Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets.  Immunity. 1998;  8 275-283
    CrossrefPubMedGoogle Scholar
  • 99 Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.  Annu Rev Immunol. 1989;  7 145-173
    CrossrefPubMedGoogle Scholar
  • 100 Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N. et al . TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.  J Exp Med. 2005;  202 1213-1223
    CrossrefPubMedGoogle Scholar
  • 101 Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, Sharfstein SE. et al . TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells.  Nat Med. 2005;  11 653-660
    PubMedGoogle Scholar
  • 102 Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A. et al . Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.  Nat Med. 2003;  9 525-532
    PubMedGoogle Scholar
  • 103 Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in drosophila adults.  Cell. 1996;  86 973-983
    CrossrefPubMedGoogle Scholar
  • 104 Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors.  Science. 2004;  304 ((5673)) 1014-1018
    CrossrefPubMedGoogle Scholar
  • 105 Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.  Nature. 1997;  388 ((6640)) 394-397
    CrossrefPubMedGoogle Scholar
  • 106 Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer.  Nat Rev Immunol. 2005;  5 296-306
    CrossrefPubMedGoogle Scholar

Correspondence

M. SchottMD 

Department of Endocrinology

Diabetology and Rheumatology

University Hospital Duesseldorf

Moorenstr. 5

40225 Duesseldorf

Germany

Phone: +49/211/811 78 10

Fax: +49/211/811 78 60

Email: matthias.schott@uni-duesseldorf.de

      >